Mostrar el registro sencillo del ítem

dc.contributor.authorPalau, Patricia
dc.contributor.authorNúñez, Gonzalo
dc.contributor.authorDe la Espriella, Rafael
dc.contributor.authorMiñana, Gema
dc.contributor.authorDomínguez Mafé, Eloy
dc.contributor.authorLorenzo, Miguel
dc.contributor.authorLópez Vilaró, Laura
dc.contributor.authorRabelo Flor, Cristina
dc.contributor.authorMarín, Paloma
dc.contributor.authorBayes-Genis, Antoni
dc.contributor.authorJuan, Sanchís
dc.contributor.authorNúñez, Julio
dc.date.accessioned2024-07-11T06:56:54Z
dc.date.available2024-07-11T06:56:54Z
dc.date.issued2024-06-12
dc.identifier.citationPalau, P., Núñez, G., de la Espriella, R., Miñana, G., Domínguez, E., Lorenzo, M., Lopez, L., Flor, C., Marin, P., Bayés, A., Sanchis J. & Núñez, J. (2024). Association between N-terminal pro-brain natriuretic peptide and maximal functional capacity in heart failure with preserved ejection fraction: The modifying role of obesity. Obesity Research & Clinical Practice.ca_CA
dc.identifier.issn1871-403X
dc.identifier.issn1878-0318
dc.identifier.urihttp://hdl.handle.net/10234/208161
dc.description.abstractThis study investigates the association between maximal functional capacity (peakVO2) and N-terminal pro-brain natriuretic peptide (NT-proBNP) in 133 ambulatory patients with heart failure with preserved ejection fraction (HFpEF), focusing on patients with obesity. Across all participants, NT-proBNP inversely correlated with peakVO2. However, this association varied based on obesity status. In patients without obesity, there was an inverse relationship between NT-proBNP and peakVO2, while no significant correlation was observed in patients with obesity. These findings suggest that in stable ambulatory HFpEF, NT-proBNP did not predict peakVO2 in patients with obesity.ca_CA
dc.format.extent6 p.ca_CA
dc.format.mimetypeapplication/pdfca_CA
dc.language.isoengca_CA
dc.publisherElsevier ScienceDirectca_CA
dc.relation.isPartOfObesity Research & Clinical Practice, Vol. 18, Issue 3 (May-June 2024)ca_CA
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/ca_CA
dc.subjectHFpEFca_CA
dc.subjectmaximal functional capacityca_CA
dc.subjectPeakVO2ca_CA
dc.subjectNT-proBNPca_CA
dc.subjectobesityca_CA
dc.titleAssociation between N-terminal pro-brain natriuretic peptide and maximal functional capacity in heart failure with preserved ejection fraction : the modifying role of obesityca_CA
dc.typeinfo:eu-repo/semantics/articleca_CA
dc.identifier.doihttps://doi.org/10.1016/j.orcp.2024.05.005
dc.rights.accessRightsinfo:eu-repo/semantics/openAccessca_CA
dc.type.versioninfo:eu-repo/semantics/publishedVersionca_CA
project.funder.nameMinisterio de Economía y Competitividad / Instituto de Salud Carlos IIIca_CA
project.funder.nameEuropean Regional Development Fund (ERDF)ca_CA
oaire.awardNumberPI17/01426ca_CA
oaire.awardNumber16/11/00420 | 16/11/00403ca_CA


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

http://creativecommons.org/licenses/by-nc-nd/4.0/
Excepto si se señala otra cosa, la licencia del ítem se describe como: http://creativecommons.org/licenses/by-nc-nd/4.0/